Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Shares Outstanding (2023 - 2025)

Mangoceuticals' Shares Outstanding history spans 3 years, with the latest figure at $980000.0 for Q3 2025.

  • For Q3 2025, Shares Outstanding rose 52588.17% year-over-year to $980000.0; the TTM value through Sep 2025 reached $980000.0, up 52588.17%, while the annual FY2024 figure was $980000.0, 31.37% down from the prior year.
  • Shares Outstanding for Q3 2025 was $82.0 at Mangoceuticals, down from $582.0 in the prior quarter.
  • Across five years, Shares Outstanding topped out at $16.8 million in Q3 2023 and bottomed at -$22.0 million in Q1 2024.
  • The 3-year median for Shares Outstanding is $980000.0 (2024), against an average of $2.8 million.
  • The largest annual shift saw Shares Outstanding plummeted 99.99% in 2024 before it surged 52588.17% in 2025.
  • A 3-year view of Shares Outstanding shows it stood at $1.4 million in 2023, then plummeted by 99.81% to $2770.0 in 2024, then soared by 35279.06% to $980000.0 in 2025.
  • Per Business Quant, the three most recent readings for MGRX's Shares Outstanding are $980000.0 (Q3 2025), $980000.0 (Q2 2025), and $980000.0 (Q1 2025).